Please login to the form below

Not currently logged in
Email:
Password:

beloranib

This page shows the latest beloranib news and features for those working in and with pharma, biotech and healthcare.

Zafgen shares tumble after FDA places hold on diabetes trial

Zafgen shares tumble after FDA places hold on diabetes trial

Like beloranib, ZGN-1061 is an injectable small molecule drug that is supposed to help the body burn more fat by inhibiting the activity of the methionine aminopeptidase 2 (MetAP2) enzyme. ... Zafgen came close to running out of cash when it was forced

Latest news

  • Second patient death in Zafgen's obesity drug trial

    A second patient enrolled in a phase III trial of Zafgen's obesity drug candidate beloranib has died, placing the future of the programme in doubt. ... Analysts suggested that the toxicity concern could give beloranib a tough time getting through

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics